Crossmark

Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s12185-021-03252-1

Published Online: 2021-11-01

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakamae, Hirohisa https://orcid.org/0000-0003-4203-990X
Nakane, Takahiko

Okamura, Hiroshi

Koh, Hideo

Nakashima, Yasuhiro

Hirose, Asao

Nakamae, Mika

Nishimoto, Mitsutaka

Kuno, Masatomo

Makuuchi, Yosuke

Harada, Naonori

Takakuwa, Teruhito

Hino, Masayuki
License Information

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2021-11-01
More Information

Article History

First Online: 1 November 2021

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below